feed,title,long_url,short_url
Benzinga,"UK Agency Says AstraZeneca's Breast Cancer Drug Enhertu Is Expensive, CEO Pascal Soriot Urges Review Of Drug Pricing Assessment",https://benzinga.com/general/biotech/24/07/39991095/uk-agency-says-astrazenecas-breast-cancer-drug-enhertu-is-expensive-ceo-pascal-soriot-urges-revie,https://da.gd/XtVM4U
Benzinga,"If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,400 Today",https://benzinga.com/insights/news/24/07/39991084/if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-4-400-today,https://da.gd/Gnoh1A
Benzinga,"$1000 Invested In This Stock 10 Years Ago Would Be Worth $9,100 Today",https://benzinga.com/insights/news/24/07/39991082/1000-invested-in-this-stock-10-years-ago-would-be-worth-9-100-today,https://da.gd/K3PPc
Benzinga,Unpacking the Latest Options Trading Trends in ON Semiconductor,https://benzinga.com/insights/options/24/07/39991076/unpacking-the-latest-options-trading-trends-in-on-semiconductor,https://da.gd/qU2tCm
Benzinga,Behind the Scenes of Oracle's Latest Options Trends,https://benzinga.com/insights/options/24/07/39991074/behind-the-scenes-of-oracles-latest-options-trends,https://da.gd/aIRpG2
Benzinga,Baidu Options Trading: A Deep Dive into Market Sentiment,https://benzinga.com/insights/options/24/07/39991072/baidu-options-trading-a-deep-dive-into-market-sentiment,https://da.gd/YzyY
